Pier Lambiase
Home EHRA 2021: Subcutaneous ICDs maintain cardioversion efficacy of 98% across five-year study the-challenge-of-monitoring-innovation-in-modern-electrophysiology-beyond-randomised-controlled-trials-time-for-a-cultural-shift
the-challenge-of-monitoring-innovation-in-modern-electrophysiology-beyond-randomised-controlled-trials-time-for-a-cultural-shift
